Literature DB >> 7032556

Haemodynamic effects of dobutamine in patients with congestive heart failure receiving captopril.

H Ikram, A H Maslowski, M G Nicholls.   

Abstract

Treatment with captopril has proved effective in some patients with resistant heart failure. Since cardiac output responses to captopril treatment are generally small, we infused the positive inotropic agent dobutamine in six patients already receiving captopril to determine whether cardiac output could be augmented without concomitantly increasing myocardial oxygen demands. At low infusion rates of dobutamine (2.5 and 5 microgram/kg per min), a substantial rise in cardiac output was observed yet myocardial oxygen uptake remained well below baseline (pre-captopril/dobutamine) levels. At higher rates of infusion (10 and 20 microgram/kg per min) the rise in cardiac output was accompanied by a pronounced increase in myocardial oxygen uptake, and the appearance of chest pain or multifocal ventricular extrasystoles in three patients. These data indicate that captopril treatment combined with low infusion rates of dobutamine can augment cardiac output in the short term, without increasing myocardial oxygen demand.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7032556      PMCID: PMC482691          DOI: 10.1136/hrt.46.5.528

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  11 in total

1.  The cardiovascular effects of the continuous infusion of dobutamine in patients with severe cardiac failure.

Authors:  C V Leier; J Webel; C A Bush
Journal:  Circulation       Date:  1977-09       Impact factor: 29.690

2.  Clinical pharmacology and therapeutic application of prazosin in acute and chronic refractory congestive heart failure. Balanced systemic venous and arterial dilation improving pulmonary congestion and cardiac output.

Authors:  N A Awan; R R Miller; M P Miller; K Specht; Z Vera; D T Mason
Journal:  Am J Med       Date:  1978-07       Impact factor: 4.965

3.  Relation of heart rate and systolic blood pressure to the onset of pain in angina pectoris.

Authors:  B F Robinson
Journal:  Circulation       Date:  1967-06       Impact factor: 29.690

4.  Treatment of chronic congestive heart failure with captopril, an oral inhibitor of angiotensin-converting enzyme.

Authors:  R Davis; H S Ribner; E Keung; E H Sonnenblick; T H LeJemtel
Journal:  N Engl J Med       Date:  1979-07-19       Impact factor: 91.245

5.  Superiority of dobutamine over dopamine for augmentation of cardiac output in patients with chronic low output cardiac failure.

Authors:  H S Loeb; J Bredakis; R M Gunner
Journal:  Circulation       Date:  1977-02       Impact factor: 29.690

6.  The rate-pressure product as an index of myocardial oxygen consumption during exercise in patients with angina pectoris.

Authors:  F L Gobel; L A Norstrom; R R Nelson; C R Jorgensen; Y Wang
Journal:  Circulation       Date:  1978-03       Impact factor: 29.690

7.  Angiotensin converting enzyme inhibition in patients with congestive heart failure.

Authors:  H Gavras; D P Faxon; J Berkoben; H R Brunner; T J Ryan
Journal:  Circulation       Date:  1978-11       Impact factor: 29.690

8.  Sustained effectiveness of converting-enzyme inhibition in patients with severe congestive heart failure.

Authors:  V J Dzau; W S Colucci; G H Williams; G Curfman; L Meggs; N K Hollenberg
Journal:  N Engl J Med       Date:  1980-06-19       Impact factor: 91.245

9.  Effects of dobutamine in patients with acute myocardial infarction.

Authors:  T A Gillespie; H D Ambos; B E Sobel; R Roberts
Journal:  Am J Cardiol       Date:  1977-04       Impact factor: 2.778

10.  Haemodynamic, hormonal, and electrolyte responses to captopril in resistant heart failure.

Authors:  A H Maslowski; H Ikram; M G Nicholls; E A Espiner
Journal:  Lancet       Date:  1981-01-10       Impact factor: 79.321

View more
  5 in total

Review 1.  The rationale for combined use of diuretics, digitalis, and vasodilators in congestive heart failure.

Authors:  T W Smith; M A Pfeffer
Journal:  Cardiovasc Drugs Ther       Date:  1989-03       Impact factor: 3.727

2.  Captopril in congestive heart failure.

Authors:  G Liebau; A J Riegger; P Schanzenbächer; H Steilner; S Oehrlein
Journal:  Br J Clin Pharmacol       Date:  1982       Impact factor: 4.335

3.  Effects of dobutamine on left ventricular performance in newborns as determined by systolic time intervals.

Authors:  H Stopfkuchen; D Schranz; R Huth; B K Jüngst
Journal:  Eur J Pediatr       Date:  1987-03       Impact factor: 3.183

Review 4.  Combination of positive inotropic and vasodilating substances in congestive heart failure.

Authors:  I Cantelli; D Bracchetti
Journal:  Cardiovasc Drugs Ther       Date:  1988-05       Impact factor: 3.727

Review 5.  Captopril: an update review of its pharmacological properties and therapeutic efficacy in congestive heart failure.

Authors:  J A Romankiewicz; R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1983-01       Impact factor: 9.546

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.